ArticlePLOS global public health2026
Disparities in long-lasting insecticidal bed net usage and malaria burden 2 years after a mass distribution campaign in central Côte d'Ivoire: A cross-sectional survey prior to a cluster randomised trial.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying and tackling inequities in long-lasting insecticidal bed net (LLIN) coverage and usage is key in reducing malaria burden. This baseline study, prior to an LLIN trial, describes factors associated with LLIN usage and malaria infection prevalence, two years after a mass distribution in Côte d'Ivoire. In July 2023, cross-sectional data were obtained from randomly selected individuals of all ages in each of 33 study clusters, capturing information on socio-economic status, LLIN ownership, usage and results of malaria rapid diagnostic tests. Random-effects multivariable logistic regression analyses were used to assess factors associated with LLIN usage and malaria infection. A total of 1,672 participants were recruited. LLIN ownership and access were 66.3% (95% CI: 59.4-73.2) and 27.8% (95%CI: 22.6-33.1), respectively. LLIN usage was 50.0% (adjusted odds ratio [aOR]: 0.50; 95%CI: 0.34-0.75), 44.3% (aOR: 0.41; 95%CI: 0.26-0.62) and 56.9% (aOR: 0.72; 95%CI: 0.53-0.98) in participants aged, 5-9, 10-14 and ≥15years, respectively, compared to 63.2% in under-fives. LLIN usage was lowest in females aged 10-14 years (41.0%) and highest in under-five males (68.9%). The odds of LLIN usage were lowest in the second (aOR: 0.63; 95%CI: 0.44-0.90) and middle wealth quintile (aOR: 0.69; 95%CI: 0.47-1.00) compared to the poorest quintile (58.2%). Malaria infection prevalence was 41.1% (95%CI: 37.2-45.0). When compared to under-fives with a malaria prevalence of 61.3%, 5-9, 10-14 and ≥15years had 75.0% (aOR: 1.86; 95%CI: 1.24-2.78), 67.0% (aOR:1.18; 95%CI: 0.78-1.80) and 23.0% (aOR: 0.17; 95%CI: 0.12-0.23) malaria prevalence, respectively. Males (75.8%) and females (74.1%) aged 5-9 years had the highest malaria risk. LLIN users had an infection prevalence of 38.5% (aOR: 0.74; 95%CI: 0.58-0.94), compared to 44.3% in non-users. School-based net distributions, malaria education, routine screening and treatment and chemoprophylaxis in schools alongside community sensitization campaigns are recommended to improve protection and reduce infection risk among school-aged children.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.